Worldquant Millennium Advisors LLC Has $41.37 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Worldquant Millennium Advisors LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 29.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 101,785 shares of the company’s stock after selling 41,477 shares during the period. Worldquant Millennium Advisors LLC’s holdings in HCA Healthcare were worth $41,368,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of HCA. CWM LLC lifted its holdings in shares of HCA Healthcare by 10.5% during the 2nd quarter. CWM LLC now owns 9,867 shares of the company’s stock worth $3,170,000 after acquiring an additional 937 shares during the period. CX Institutional increased its stake in shares of HCA Healthcare by 13.1% in the 2nd quarter. CX Institutional now owns 2,090 shares of the company’s stock valued at $672,000 after purchasing an additional 242 shares during the last quarter. CHICAGO TRUST Co NA bought a new stake in shares of HCA Healthcare during the 2nd quarter worth $200,000. Sax Wealth Advisors LLC acquired a new position in HCA Healthcare during the second quarter worth about $332,000. Finally, Sound Income Strategies LLC boosted its stake in shares of HCA Healthcare by 532.7% in the 2nd quarter. Sound Income Strategies LLC now owns 348 shares of the company’s stock valued at $112,000 after purchasing an additional 293 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $320.04 on Friday. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company’s fifty day moving average price is $365.52 and its two-hundred day moving average price is $358.39. The company has a market cap of $81.07 billion, a price-to-earnings ratio of 14.37, a PEG ratio of 1.26 and a beta of 1.63. HCA Healthcare, Inc. has a 1-year low of $251.55 and a 1-year high of $417.14.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.82%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the stock. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price target for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Finally, Royal Bank of Canada raised their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.